CA9, carbonic anhydrase 9, 768

N. diseases: 226; N. variants: 4
Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs3829078
rs3829078
Entrez Id: 768
Gene Symbol: CA9
CA9
CUI: C1269955
Disease:
Tumor Cell Invasion
0.010 GeneticVariation BEFREE Furthermore, patients with CaP with an initial PSA level ≤10 ng/ml who carried at least one G allele at CA9 rs3829078 had a 4.532-fold and 3.484-fold risk of lymph node metastasis and lymphovascular invasion, respectively. 31155437 2019
dbSNP: rs3829078
rs3829078
Entrez Id: 768
Gene Symbol: CA9
CA9
CUI: C0600139
Disease:
Prostate carcinoma
0.010 GeneticVariation BEFREE The rs3829078 polymorphic genotype of CA9 can predict the risk of lymph node metastasis of CaP with an initial PSA level ≤10 ng/ml. 31155437 2019
dbSNP: rs3829078
rs3829078
Entrez Id: 768
Gene Symbol: CA9
CA9
CUI: C0376358
Disease:
Malignant neoplasm of prostate
0.010 GeneticVariation BEFREE The rs3829078 polymorphic genotype of CA9 can predict the risk of lymph node metastasis of CaP with an initial PSA level ≤10 ng/ml. 31155437 2019
dbSNP: rs3829078
rs3829078
Entrez Id: 768
Gene Symbol: CA9
CA9
CUI: C0686619
Disease:
Secondary malignant neoplasm of lymph node
0.010 GeneticVariation BEFREE The rs3829078 polymorphic genotype of CA9 can predict the risk of lymph node metastasis of CaP with an initial PSA level ≤10 ng/ml. 31155437 2019
dbSNP: rs1048638
rs1048638
Entrez Id: 768
Gene Symbol: CA9
CA9
CUI: C0007137
Disease:
Squamous cell carcinoma
0.010 GeneticVariation BEFREE In conclusion, CA9 SNP rs1048638 and haplotype A1AA are associated with the susceptibility of cervical invasive squamous cell carcinoma for Taiwanese women. 29725249 2018
dbSNP: rs2071676
rs2071676
Entrez Id: 768;84904
Gene Symbol: CA9;ARHGEF39
CA9;ARHGEF39
CUI: C0677898
Disease:
invasive cancer
0.010 GeneticVariation BEFREE AA in SNP rs2071676 tended to increase the risk of developing cervical invasive cancer, using GG/GA as a reference. 29725249 2018
dbSNP: rs1048638
rs1048638
Entrez Id: 768
Gene Symbol: CA9
CA9
CUI: C4048328
Disease:
cervical cancer
0.010 GeneticVariation BEFREE In conclusion, the finding that the <i>CA9</i> </span>SNP rs1</span>048638 exerts its action through duplexes of the miR-34a and <i>CA9</i> 3'-UTRs and plays a vital role in cervical cancer in Taiwanese women may be applicable to translational medicine. 29100431 2017
dbSNP: rs1048638
rs1048638
Entrez Id: 768
Gene Symbol: CA9
CA9
CUI: C0302592
Disease:
Cervix carcinoma
0.010 GeneticVariation BEFREE In conclusion, the finding that the <i>CA9</i> </span>SNP rs1</span>048638 exerts its action through duplexes of the miR-34a and <i>CA9</i> 3'-UTRs and plays a vital role in cervical cancer in Taiwanese women may be applicable to translational medicine. 29100431 2017
dbSNP: rs1048638
rs1048638
Entrez Id: 768
Gene Symbol: CA9
CA9
CUI: C0027651
Disease:
Neoplasms
0.010 GeneticVariation BEFREE Here, we found that people carry A allele at CA9 rs1048638, a 3'UTR SNP, has higher risk of HCC. rs1048638-CA correlates with advanced stages, larger tumor sizes, more vascular invasion, and shorter survival of HCC patients. 28667334 2017
dbSNP: rs1048638
rs1048638
Entrez Id: 768
Gene Symbol: CA9
CA9
CUI: C0007847
Disease:
Malignant tumor of cervix
0.010 GeneticVariation BEFREE In conclusion, the finding that the <i>CA9</i> </span>SNP rs1</span>048638 exerts its action through duplexes of the miR-34a and <i>CA9</i> 3'-UTRs and plays a vital role in cervical cancer in Taiwanese women may be applicable to translational medicine. 29100431 2017
dbSNP: rs1048638
rs1048638
Entrez Id: 768
Gene Symbol: CA9
CA9
CUI: C2239176
Disease:
Liver carcinoma
0.010 GeneticVariation BEFREE CA9 expression levels were also correlated with miR-34a levels and rs1048638 genotypes in HCC patients. rs1048638 influences HCC risk and progression through effects on miR-34a-targeted CA9 expression in HCC. 28667334 2017
dbSNP: rs1048638
rs1048638
Entrez Id: 768
Gene Symbol: CA9
CA9
CUI: C0677898
Disease:
invasive cancer
0.010 GeneticVariation BEFREE Moreover, among the UCC patients with smoker, people with at least one A allele of CA9 polymorphisms (rs1048638) had a 4.75-fold (95% CI = 1.204-18.746) increased risk of invasive cancer. 24349364 2013
dbSNP: rs1048638
rs1048638
Entrez Id: 768
Gene Symbol: CA9
CA9
CUI: C0596263
Disease:
Carcinogenesis
0.010 GeneticVariation BEFREE Our results suggest that the haplotype of rs2071676, rs3829078, and rs1048638 combined has potential predictive significance in oral carcinogenesis. 23226559 2012
dbSNP: rs1048638
rs1048638
Entrez Id: 768
Gene Symbol: CA9
CA9
CUI: C0220641
Disease:
Lip and Oral Cavity Carcinoma
0.010 GeneticVariation BEFREE While the studied SNPs (CA9 rs2071676, rs3829078, rs1048638 and +376 Del) were not associated with susceptibility to oral cancer, the GAA haplotype of 3 CA9 SNPs (rs2071676, rs3829078, and rs1048638) was related to a higher risk of oral cancer. 23226559 2012
dbSNP: rs1048638
rs1048638
Entrez Id: 768
Gene Symbol: CA9
CA9
CUI: C0153381
Disease:
Malignant neoplasm of mouth
0.010 GeneticVariation BEFREE While the studied SNPs (CA9 rs2071676, rs3829078, rs1048638 and +376 Del) were not associated with susceptibility to oral cancer, the GAA haplotype of 3 CA9 SNPs (rs2071676, rs3829078, and rs1048638) was related to a higher risk of oral cancer. 23226559 2012
dbSNP: rs2071676
rs2071676
Entrez Id: 768;84904
Gene Symbol: CA9;ARHGEF39
CA9;ARHGEF39
CUI: C0220641
Disease:
Lip and Oral Cavity Carcinoma
0.010 GeneticVariation BEFREE While the studied SNPs (CA9 rs2071</span>676, rs3829078, rs1048638 and +376 Del) were not associated with susceptibility to oral cancer, the GAA haplotype of 3 CA9 SNPs (rs2071676, rs3829078, and rs1048638) was related to a higher risk of oral cancer. 23226559 2012
dbSNP: rs2071676
rs2071676
Entrez Id: 768;84904
Gene Symbol: CA9;ARHGEF39
CA9;ARHGEF39
CUI: C0153381
Disease:
Malignant neoplasm of mouth
0.010 GeneticVariation BEFREE While the studied SNPs (CA9 rs2071</span>676, rs3829078, rs1048638 and +376 Del) were not associated with susceptibility to oral cancer, the GAA haplotype of 3 CA9 SNPs (rs2071676, rs3829078, and rs1048638) was related to a higher risk of oral cancer. 23226559 2012
dbSNP: rs2071676
rs2071676
Entrez Id: 768;84904
Gene Symbol: CA9;ARHGEF39
CA9;ARHGEF39
CUI: C0686619
Disease:
Secondary malignant neoplasm of lymph node
0.010 GeneticVariation BEFREE Finally, patients with oral cancer who had at least one G allele of CA9 rs2071676 were at higher risk for developing lymph-node metastasis (p = 0.022), compared to those patients homozygous for AA. 23226559 2012
dbSNP: rs3829078
rs3829078
Entrez Id: 768
Gene Symbol: CA9
CA9
CUI: C0220641
Disease:
Lip and Oral Cavity Carcinoma
0.010 GeneticVariation BEFREE While the studied SNPs (CA9 rs2071676, rs3829078, rs1048638 and +376 Del) were not associated with susceptibility to oral cancer, the GAA haplotype of 3 CA9 SNPs (rs2071676, rs3829078, and rs1048638) was related to a higher risk of oral cancer. 23226559 2012
dbSNP: rs3829078
rs3829078
Entrez Id: 768
Gene Symbol: CA9
CA9
CUI: C0153381
Disease:
Malignant neoplasm of mouth
0.010 GeneticVariation BEFREE While the studied SNPs (CA9 rs2071676, rs3829078, rs1048638 and +376 Del) were not associated with susceptibility to oral cancer, the GAA haplotype of 3 CA9 SNPs (rs2071676, rs3829078, and rs1048638) was related to a higher risk of oral cancer. 23226559 2012
dbSNP: rs12553173
rs12553173
Entrez Id: 768;84904
Gene Symbol: CA9;ARHGEF39
CA9;ARHGEF39
CUI: C0279702
Disease:
Conventional (Clear Cell) Renal Cell Carcinoma
0.010 GeneticVariation BEFREE CA9 rs12553173 and CAIX are independent prognostic factors of overall survival and complementary for predicting the prognosis of metastatic clear cell renal cell carcinoma. 19539328 2009